The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma
-
* Corresponding author: John Hsu jth@dor.kaiser.org
BMC Health Services Research 2008, 8:151 doi:10.1186/1472-6963-8-151
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 04 Dec 2007 | |
| Reviewer's Report | Michael Fischer | 23 Jan 2008 | |
| Reviewer's Report | Neal Wallace | 25 Feb 2008 | |
| Reviewer's Report | Donald Klepser | 04 Mar 2008 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 03 Apr 2008 |
| Reviewer's Report | Michael Fischer | 16 Apr 2008 | |
| Reviewer's Report | Neal Wallace | 07 May 2008 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 03 Jun 2008 |
| Reviewer's Report | Michael Fischer | 13 Jun 2008 | |
| Editorial acceptance | 24 Jun 2008 | ||
| Published | 18 Jul 2008 |